Vericel (VCEL) EV to FCF (2010 - 2026)
Powered by 
Analysis
Vericel (VCEL) EV to FCF (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 146.17 |
| Mar 31, 2026 | 100.23 |
| Dec 31, 2025 | 131.39 |
| Sep 30, 2025 | 74.82 |
| Jun 30, 2025 | 25,054.12 |
| Mar 31, 2025 | -279.73 |
| Dec 31, 2024 | 308.56 |
| Sep 30, 2024 | -214.60 |
| Jun 30, 2024 | 1,205.91 |
| Mar 31, 2024 | -353.89 |
| Dec 31, 2023 | 707.97 |
| Sep 30, 2023 | 2,488.37 |
| Jun 30, 2023 | 246.19 |
| Mar 31, 2023 | 228.33 |
| Dec 31, 2022 | 200.13 |
| Sep 30, 2022 | 365.57 |
| Jun 30, 2022 | 934.87 |
| Mar 31, 2022 | 4,389.89 |
| Dec 31, 2021 | 181.90 |
| Sep 30, 2021 | 1,865.02 |